机译:两种逆转录酶抑制剂EFdA和CSIC的阴道杀菌剂薄膜组合,用于预防HIV-1性传播
Magee Womens Research Institute University of Pittsburgh">(1);
Department of Pharmaceutical Sciences School of Pharmacy University of Pittsburgh">(2);
Magee Womens Research Institute University of Pittsburgh">(1);
Department of Pharmaceutical Sciences School of Pharmacy University of Pittsburgh">(2);
Magee Womens Research Institute University of Pittsburgh">(1);
Department of Pharmaceutical Sciences School of Pharmacy University of Pittsburgh">(2);
Magee Womens Research Institute University of Pittsburgh">(1);
Department of Pharmaceutical Sciences School of Pharmacy University of Pittsburgh">(2);
Magee Womens Research Institute University of Pittsburgh">(1);
Department of Obstetrics Gynecology and Reproductive Sciences School of Medicine University of Pittsburgh">(3);
Magee Womens Research Institute University of Pittsburgh">(1);
Department of Obstetrics Gynecology and Reproductive Sciences School of Medicine University of Pittsburgh">(3);
Department of Molecular Microbiology Immunology School of Medicine University of Missouri">(4);
Department of Microbiology and Molecular Genetics School of Medicine University of Pittsburgh">(5);
Magee Womens Research Institute University of Pittsburgh">(1);
Department of Pharmaceutical Sciences School of Pharmacy University of Pittsburgh">(2);
Department of Obstetrics Gynecology and Reproductive Sciences School of Medicine University of Pittsburgh">(3);
机译:两种逆转录酶抑制剂EFdA和CSIC的阴道杀菌剂薄膜组合,用于预防HIV-1性传播
机译:含EFdA(一种新型抗HIV核苷逆转录酶抑制剂)的阴道分娩膜的研制
机译:含有EFDA的阴道输送膜的研制,一种新型抗HIV核苷逆转录酶抑制剂
机译:淋巴细胞活化羟基脲(HU),牛(DX)和三苯并(TX)的抑制剂的组合与逆转录酶抑制剂(RTI)组合:ABACAVIR(ABC),脱氨酸(DDI)和替诺福韦(TFV) IMMUN的鼠模型
机译:非核苷类逆转录酶抑制剂单独或与其他逆转录酶抑制剂合用可阻断HIV-1复制的机制
机译:两种逆转录酶抑制剂EFdA和CSIC的阴道杀菌膜组合用于预防HIV-1性传播
机译:含有大哌啶的阴道薄膜的开发和表征,非核苷逆转录酶抑制剂(NNRTI),用于预防HIV-1性传播